GPER1 and cancer: Activation of GPER generally promotes proliferation and proliferative signaling pathways in endometrial [52], thyroid [51], and ovarian [91] cancer cell lines, although inhibition of proliferation has been reported in breast [97] and pancreatic cell lines [89].